title: Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist.
abstract: We have previously reported that ropinirole, a non-ergot dopamine agonist, has neuroprotective effects against 6-hydroxydopamine in mice based on in vivo antioxidant properties such as the glutathione (GSH)-activating effect. In the present study, we determined that the effects of ropinirole on the level of expression of GSH-related enzyme mRNA, these enzymes were shown to regulate GSH contents in the brain. This study focused on the mechanism of GSH enhancement by ropinirole. Striatal GSH contents were significantly increased by 7-day daily administration of ropinirole. Furthermore, the expression levels of gamma-glutamylcysteine synthetase (gamma-GCS), glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione S-transferase (GST) mRNA increased following daily injections of ropinirole for 7 days. In addition, ropinirole treatment for 7 days suppressed auto-oxidation in mouse striatal homogenates, in contrast to the vehicle treatment. In conclusion, ropinirole was able to suppress auto-oxidation, most probably by increasing GSH levels due to an increase of GSH synthesis. In addition, it is likely that auto-oxidation was also suppressed by the activation of GSH-regulating enzymes such as GPx, GR, and GST in the mouse striatum. Thus, our results indicate that the GSH-activating effect of ropinirole may render this dopamine agonist beneficial as a neuroprotective drug.
authors.affiliation: Department of Neuroscience, Institute of Molecular and Cellular Medicine, Okayama University Medical School, Japan. kntanaka@cc.okayama-u.ac.jp
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
authors.forename: I
authors.initials: I
authors.lastname: Miyazaki
authors.forename: N
authors.initials: N
authors.lastname: Fujita
authors.forename: M E
authors.initials: ME
authors.lastname: Haque
authors.forename: M
authors.initials: M
authors.lastname: Asanuma
authors.forename: N
authors.initials: N
authors.lastname: Ogawa
mesh_terms: D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D018491:Dopamine Agonists / Q000494:pharmacology*; D004334:Drug Administration Schedule; D005978:Glutathione / Q000235:genetics / Q000378:metabolism*; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D010084:Oxidation-Reduction / Q000187:drug effects; D012333:RNA, Messenger / Q000378:metabolism; D017448:Receptors, Dopamine D2 / Q000819:agonists*; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism
chemical_list: D018491:Dopamine Agonists; D007211:Indoles; D012333:RNA, Messenger; D017448:Receptors, Dopamine D2; D017392:Thiobarbituric Acid Reactive Substances; C046649:ropinirole; D005978:Glutathione